SCHEMBL1795944

SCHEMBL1795944

O=C(COCC(=O)N(Cc1ccc(C(F)(F)F)cc1)Cc1ccc(C(F)(F)F)cc1)Nc1ccc(Cl)cc1C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SERPINE1 P05121 4/20 0.45
▸ POLB P06746 1/20 0.44
▸ G6PD P11413 1/20 0.44
▸ GRIK1 P39086 1/20 0.43
▸ MPO P05164 1/20 0.43
▸ PPARG P37231 1/20 0.43
▸ PPARD Q03181 1/20 0.43
▸ NR1H4 Q96RI1 1/20 0.43
▸ LMNA P02545 2/20 0.42
▸ KCNK2 O95069 1/20 0.42
▸ KCNK10 P57789 1/20 0.42
▸ PLK1 P53350 1/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ HSPH1 Q92598 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ HTT P42858 1/20 0.40
▸ ASPH Q12797 1/20 0.40
▸ RIOX2 Q8IUF8 1/20 0.40
▸ KDM8 Q8N371 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1796795 0.90 LMNA (0.45) PPARGPPARDNR1H4LMNAKDM4E
SCHEMBL1799453 0.89 POLB (0.48) SERPINE1POLBG6PDLMNAKDM4E
SCHEMBL1798680 0.88 POLB (0.48) SERPINE1POLBG6PDLMNAKDM4E
SCHEMBL1799415 0.80 MPO (0.55) SERPINE1POLBG6PDGRIK1MPO
SCHEMBL1797143 0.79 MAPT (0.44) POLBLMNAKDM4EHSD17B10GAA
SCHEMBL1798678 0.79 MAPT (0.42) SERPINE1POLBG6PDPPARGLMNA
SCHEMBL27519919 0.78 HCAR2 (0.55) SERPINE1GRIK1MPOPPARGPPARD
SCHEMBL1841029 0.77 SERPINE1 (0.57) SERPINE1POLBG6PDLMNAKCNK2
SCHEMBL1798112 0.75 SERPINE1 (0.56) SERPINE1POLBG6PDLMNAKDM4E
SCHEMBL1797141 0.74 SERPINE1 (0.55) SERPINE1POLBG6PDLMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951806-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2011-05-31 — — US claimed
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 — — US claimed
US-10092537-B2 Use for PAI-1 inhibitor RENASCIENCE CO., LTD. (JP) 2018-10-09 — — US disclosed
US-20160158188-A1 NOVEL USE FOR PAI-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2016-06-09 — — US disclosed
EP-2990057-A1 NOVEL USE FOR PAI-1 INHIBITOR Renascience Co., Ltd. (JP) 2016-03-02 — — EP disclosed
US-7951806-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2011-05-31 — — US disclosed
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160158188-A1 NOVEL USE FOR PAI-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 SERPINE1 1/4885POLB 2824/4885G6PD 387/4885
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 SERPINE1 1/4885POLB 2674/4885G6PD 815/4885
US-10092537-B2 Use for PAI-1 inhibitor SERPINE1, SERPINC1, SERPINB1 SERPINE1 1/4885POLB 2556/4885G6PD 254/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback